Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Synthetic retinoids with anticoagulant effects

Sep. 15, 1997

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

Heparinase gene covered by U.S., European patents

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

Reteplase and alteplase exhibit different profiles of fibrin binding at high doses

Sep. 10, 1997

U.S. patent for antithrombotic agents issued to Burnham Institute

Sep. 10, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

RPR discloses new factor Xa inhibitors

Sep. 10, 1997

Promising phase II results for Genzyme Transgenics' rhATIII

Sep. 9, 1997

Novastan granted priority review status by FDA

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...